BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 28 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,580,938 | -11.3% | 1,621,749 | +12.7% | 0.00% | -25.0% |
Q2 2023 | $36,737,749 | +14.6% | 1,439,567 | -4.5% | 0.00% | +33.3% |
Q1 2023 | $32,069,822 | +50.2% | 1,507,749 | +109.0% | 0.00% | +50.0% |
Q4 2022 | $21,358,146 | +6.8% | 721,559 | -16.1% | 0.00% | -33.3% |
Q3 2022 | $20,000,000 | +45.1% | 859,851 | +4.7% | 0.00% | +50.0% |
Q2 2022 | $13,780,000 | +257.3% | 821,204 | +834.1% | 0.00% | +100.0% |
Q1 2022 | $3,857,000 | -57.8% | 87,917 | -41.4% | 0.00% | 0.0% |
Q4 2021 | $9,131,000 | +51.8% | 150,012 | +3.7% | 0.00% | 0.0% |
Q3 2021 | $6,015,000 | +199.3% | 144,613 | +118.4% | 0.00% | – |
Q2 2021 | $2,010,000 | +2900.0% | 66,206 | +2855.6% | 0.00% | – |
Q1 2021 | $67,000 | +8.1% | 2,240 | -35.5% | 0.00% | – |
Q4 2020 | $62,000 | -18.4% | 3,472 | -13.0% | 0.00% | – |
Q3 2020 | $76,000 | +38.2% | 3,989 | +14.8% | 0.00% | – |
Q2 2020 | $55,000 | +25.0% | 3,474 | +6.7% | 0.00% | – |
Q1 2020 | $44,000 | – | 3,255 | +32450.0% | 0.00% | – |
Q4 2019 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |